Merck to sell generics to Mylan for 4.9 bn euros

Updated on May 13, 2007 04:15 PM IST
German drugs and chemicals group Merck KGaA said it had signed a share purchase agreement with Mylan Laboratories Inc under which the US firm will acquire its generics business for 4.9 bn euros.
HT Image
HT Image
Reuters | By, Berlin

German drugs and chemicals group Merck KGaA said on Sunday it had signed a share purchase agreement with Mylan Laboratories Inc under which the US firm will acquire its generics business for 4.9 billion euros.

Merck said the agreement was subject to regulatory approval and that it expected the transaction to close in the second half of 2007.

SHARE THIS ARTICLE ON
Close Story
SHARE
Story Saved
×
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Monday, August 08, 2022
Start 15 Days Free Trial Subscribe Now